Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide

Cui,Liming; Gao,Bo; Cao,Zhigang; Chen,Xiaoying; Zhang,Shide; Zhang,Weizhe

doi:10.3892/mmr.2016.4757

Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide

Authors:
- Liming Cui
- Bo Gao
- Zhigang Cao
- Xiaoying Chen
- Shide Zhang
- Weizhe Zhang
View Affiliations

Affiliations: Department of Interventional Radiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China, Department of Radiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China, Department of Parasitology, Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China
Published online on: January 12, 2016 https://doi.org/10.3892/mmr.2016.4757
Pages: 2032-2038
Copyright: © Cui et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Arsenic trioxide (As2O3; ATO), a compound which is characterized by its ability to function as a potent anticancer agent, has been investigated in a variety of carcinomas. B7‑H4, a transmembrane protein, may inhibit the function of the T cell effector, and therefore, may be useful in investigating different types of tumor therapies. However, few studies have been published previously associated with the roles of ATO and B7‑H4 in human hepatocellular carcinoma (HCC). The aim of the present study was to investigate the anti‑invasive role of ATO in HCC, to determine the effect of ATO treatment on the expression of B7‑H4 and to further assess the possible underlying mechanisms. Following treatment of the cells with 2, 4 and 8 µM ATO for 48 h, cell counting kit‑8 (CCK‑8), Transwell and western blot assays were used to determine the extent of human MHCC97‑H HCC cell proliferation, apoptosis, invasion and B7‑H4 expression, respectively. The results revealed that 1 µM ATO markedly decreased cellular proliferation, and ATO administered at concentrations of 0.1, 0.2 and 0.5 µM markedly inhibited the migration and invasion of the human MHCC97‑H HCC cell line. The expression of B7‑H4 in the treatment groups was markedly reduced. Signal transduction mediated via the Janus kinase 2/signal transducers and activators of transcription 3 pathway was inhibited upon treatment with 0.1, 0.2 and 0.5 µM ATO. Additionally, the protein expression levels of matrix metalloproteinase 2 and vascular endothelial growth factor were markedly reduced in HCC cells upon treatment with ATO. In conclusion, ATO may reduce the protein expression levels of B7‑H4 in MHCC97‑H HCC cells, and further affected HCC tumorigenesis and progression. ATO may be a putative agent for the development of therapeutic strategies against human liver cancer.

View Figures

View References

1	Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM and Matrisian LM: Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver and pancreas cancers in the United States. Cancer Res. 74:2913–2921. 2014. View Article : Google Scholar : PubMed/NCBI
2	Arciello M and Balsano C: Pathogenesis of hepatocellular carcinoma: New ideas for a targeted therapy. Hot Top Viral Hepatitis. 9:272013.
3	Shin JW and Chung YH: Molecular targeted therapy for hepatocellular carcinoma: Current and future. World J Gastroenterol. 19:6144–6155. 2013. View Article : Google Scholar : PubMed/NCBI
4	Page AJ, Weiss MJ and Pawlik TM: Surgical management of noncolorectal cancer liver metastases. Cancer. 120:3111–3121. 2014. View Article : Google Scholar : PubMed/NCBI
5	Tomimaru Y, Sasaki Y, Yamada T, Gotoh K, Noura S, Eguchi H, Miyashiro I, Ohue M, Ohigashi H, Yano M, et al: Liver metastasis originating from colorectal cancer with macroscopic portal vein tumor thrombosis: A case report and review of the literature. J Med Case Rep. 4:3822010. View Article : Google Scholar : PubMed/NCBI
6	Wu DD, Xiao YF, Geng Y and Hou J: Antitumor effect and mechanisms of arsenic trioxide on subcutaneously implanted human gastric cancer in nude mice. Cancer Genet Cytogenet. 198:90–96. 2010. View Article : Google Scholar : PubMed/NCBI
7	Kumar S, Yedjou CG and Tchounwou PB: Arsenic trioxide induces oxidative stress, DNA damage and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells. J Exp Clin Cancer Res. 33:422014. View Article : Google Scholar
8	Fu HY, Shen JZ, Wu Y, Shen SF, Zhou HR and Fan LP: Arsenic trioxide inhibits DNA methyltransferase and restores expression of methylation-silenced CDKN2B/CDKN2A genes in human hematologic malignant cells. Oncol Rep. 24:335–343. 2010.PubMed/NCBI
9	Kim EY, Lee SS, Shin JH, Kim SH, Shin DH and Baek SY: Anticancer effect of arsenic trioxide on cholangiocarcinoma: In vitro experiments and in vivo xenograft mouse model. Clin Exp Med. 14:215–224. 2014. View Article : Google Scholar
10	Liu P, Xu S, Zhang M, Wang WW, Zhang YF, Rehman K, Naranmandura H and Chen Z: Anticancer activity in human multiple myeloma U266 cells: Synergy between cryptotanshinone and arsenic trioxide. Metallomics. 5:871–878. 2013. View Article : Google Scholar : PubMed/NCBI
11	Liu W, Shibata K, Koya Y, Kajiyama H, Senga T, Yamashita M and Kikkawa F: B7-H4 overexpression correlates with a poor prognosis for cervical cancer patients. Mol Clin Oncol. 2:219–225. 2014.PubMed/NCBI
12	Chen L, Lu Y, Wang F, Zhou M, Chu Y, Ding W, Liu C, Xie J, Wu C and Jiang J: Expression of co-stimulatory molecule B7-H4 in patients suffering from rheumatoid arthritis. Immuno Lett. 154:25–30. 2013. View Article : Google Scholar
13	Dangaj D and Scholler N: Blocking the B7-H4 pathway with novel recombinant antibodies enhances T cell-mediated antitumor responses. Oncoimmunology. 2:e259132013. View Article : Google Scholar : PubMed/NCBI
14	Kristensen NN, Schmidt EG, Rasmussen S, Balk-Møller E and Claesson MH: B7-H4-Ig treatment of normal mice changes lymphocyte homeostasis and increases the potential of regulatory T cells. Immunopharmacol Immunotoxicol. 35:505–513. 2013. View Article : Google Scholar : PubMed/NCBI
15	Cheng L, Jiang J, Gao R, Wei S, Nan F, Li S and Kong B: B7-H4 expression promotes tumorigenesis in ovarian cancer. Int J Gynecol Cancer. 19:1481–1486. 2009. View Article : Google Scholar : PubMed/NCBI
16	Sun Y, Wang Y, Zhao J, Gu M, Giscombe R, Lefvert AK and Wang X: B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer. 53:143–151. 2006. View Article : Google Scholar : PubMed/NCBI
17	Darmochwal-Kolarz D, Kludka-Sternik M, Kolarz B, Chmielewski T, Tabarkiewicz J, Rolinski J, Leszczynska-Gorzelak B and Oleszczuk J: The expression of B7-H1 and B7-H4 co-stimulatory molecules on myeloid and plasmacytoid dendritic cells in pre-eclampsia and normal pregnancy. J Reprod Immunol. 99:33–38. 2013. View Article : Google Scholar : PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
19	Abubaker K, Luwor RB, Escalona R, McNally O, Quinn MA, Thompson EW, Findlay JK and Ahmed N: Targeted disruption of the JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem cells leading to a reduced tumor burden. Fron Oncol. 4:752014.
20	Li S, Shen X, Yang Z, Wu A, Tang Z, Li M and Ling Y: Clinical significance of MMP2 overexpression in endometrial adenocarcinoma. J South Med U. 34:423–425. 2014.In Chinese.
21	Yilmaz N, Ozaksit G, Terzi YK, Yılmaz S, Budak B, Aksakal O and Sahin Fİ: HOXA11 and MMP2 gene expression in uterosacral ligaments of women with pelvic organ prolapse. J Turk Ger Gynecol Assoc. 15:104–108. 2014. View Article : Google Scholar : PubMed/NCBI
22	Min BS, Kim NK, Jeong HC and Chung HC: High levels of serum VEGF and TIMP-1 are correlated with colon cancer liver metastasis and intrahepatic recurrence after liver resection. Oncol Lett. 4:123–130. 2012.PubMed/NCBI
23	Huang H, Li Y, Li C, Wang Y, Sun Y and Wang J: A novel anti-VEGF targeting and MRI-visible smart drug delivery system for specific diagnosis and therapy of liver cancer. Macromol Biosci. 13:1358–1368. 2013. View Article : Google Scholar : PubMed/NCBI
24	Podojil JR, Liu LN, Marshall SA, Chiang MY, Goings GE, Chen L, Langermann S and Miller SD: B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanisms. J Autoimmun. 44:71–81. 2013. View Article : Google Scholar : PubMed/NCBI
25	Krambeck AE, Thompson RH, Dong H, Lohse CM, Park ES, Kuntz SM, Leibovich BC, Blute ML, Cheville JC and Kwon ED: B7-H4 expression in renal cell carcinoma and tumor vasculature: Associations with cancer progression and survival. Proc Natl Acad Sci USA. 103:10391–10396. 2006. View Article : Google Scholar : PubMed/NCBI
26	Cheng L, Jiang J, Gao R, Wei S, Nan F, Li S and Kong B: B7-H4 expression promotes tumorigenesis in ovarian cancer. Int J Gynecol Cancer. 19:1481–1486. 2009. View Article : Google Scholar : PubMed/NCBI
27	Qian Y, Hong B, Shen L, Wu Z, Yao H and Zhang L: B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells. Cell Tissue Res. 353:139–151. 2013. View Article : Google Scholar : PubMed/NCBI
28	Sun SQ, Jiang CG, Lin Y, Jin YL and Huang PL: Enhanced T cell immunity by B7-H4 downregulation in nonsmall-cell lung cancer cell lines. J Int Med Res. 40:497–506. 2012. View Article : Google Scholar : PubMed/NCBI
29	Sarkar S, Mukherjee S, Chattopadhyay A and Bhattacharya S: Low dose of arsenic trioxide triggers oxidative stress in zebrafish brain: Expression of antioxidant genes. Ecotoxicol Environ Saf. 107:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
30	Radenkovic S, Konjevic G, Jurisic V, Karadzic K, Nikitovic M and Gopcevic K: Values of MMP-2 and MMP-9 in tumor tissue of basal-like breast cancer patients. Cell Biochem Biophys. 68:143–152. 2014. View Article : Google Scholar
31	Wang J, Shi Q, Yuan TX, Song QL, Zhang Y, Wei Q, Zhou L, Luo J, Zuo G, Tang M, et al: Matrix metalloproteinase 9 (MMP-9) in osteosarcoma: Review and meta-analysis. Clin Chimica Acta. 433:225–231. 2014. View Article : Google Scholar